TickerFactsScreenerDevelopers

Oruka Therapeutics, Inc. (ORKA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $7.76M2010: $7.03M2011: $5.94M2012: $2.92M2013: $16.76M2014: $15.35M2015: $38.80M2016: $7.40M2017: $8.70M2018: $6.61M2019: $8.36M2020: $49.07M2021: $53.36M2022: $42.45M2023: $37.43M2024: $61.58M2025: $46.94M$46.94M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$46.94M-23.8%
2024$61.58M+64.5%
2023$37.43M-11.8%
2022$42.45M-20.5%
2021$53.36M+8.7%
2020$49.07M+486.8%
2019$8.36M+26.6%
2018$6.61M-24.1%
2017$8.70M+17.6%
2016$7.40M-80.9%
2015$38.80M+152.7%
2014$15.35M-8.4%
2013$16.76M+473.8%
2012$2.92M-50.9%
2011$5.94M-15.4%
2010$7.03M-9.5%
2009$7.76M—